CBL0137
Product Specifications
CAS Number
1197996-80-7
Target
P53|||MDM-2/p53|||NF-?B|||Histone Acetyltransferase
Related Pathways
Chromatin/Epigenetic|||NF-?B|||Apoptosis
Purity
0.9968
Bioactivity
CBL0137 (Curaxin 137), a metabolically stable curaxin, activates p53 (EC50: 0.37 ?M) and inhibits NF-?B (EC50: 0.47 ?M) . It functionally inactivates the facilitates chromatin transcription complex (FACT), driving the effects on p53 and NF-?B and promoting cancer cell death. CBL0137 has broad anticancer activity in mice when administered orally, eradicates drug-resistant cancer stem cells, and potentiates the efficacy of gemcitabine in preClinicalal models of pancreatic cancer.
Smiles
C(CNC(C)C)N1C=2C(C=3C1=CC=C(C(C)=O)C3)=CC(C(C)=O)=CC2
Molecular Formula
C21H24N2O2
Molecular Weight
336.43
Shipping Conditions
Cool pack
Storage Temperature
-20°C
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS6213505-01 0.1 mL
RAD17 (Cell Cycle Checkpoint Protein RAD17, hRad17, RF-C/Activator 1 Homolog, R24L, FLJ41520) (MaxLight 550)
Ask
View Details 
MBS6213505-02 5x 0.1 mL
RAD17 (Cell Cycle Checkpoint Protein RAD17, hRad17, RF-C/Activator 1 Homolog, R24L, FLJ41520) (MaxLight 550)
Ask
View Details 